The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ANAPTYSBIO INC | COM | 032724106 | 7,662,641 | 357,733 | SH | SOLE | 357,733 | 0 | 0 | |||
AVIDITY BIOSCIENCES INC | COM | 05370A108 | 6,023,273 | 665,555 | SH | SOLE | 665,555 | 0 | 0 | |||
BIOHAVEN LTD | COM | G1110E107 | 17,118,802 | 399,972 | SH | SOLE | 399,972 | 0 | 0 | |||
CELLDEX THERAPEUTICS INC NEW | COM NEW | 15117B202 | 19,721,728 | 497,270 | SH | SOLE | 497,270 | 0 | 0 | |||
CIDARA THERAPEUTICS INC | COM | 171757107 | 900,802 | 1,134,511 | SH | SOLE | 1,134,511 | 0 | 0 | |||
COGENT BIOSCIENCES INC | COM | 19240Q201 | 4,647,787 | 790,440 | SH | SOLE | 790,440 | 0 | 0 | |||
DIANTHUS THERAPEUTICS INC | COM | 252828108 | 15,311,546 | 1,472,264 | SH | SOLE | 1,472,264 | 0 | 0 | |||
DISC MEDICINE INC | COM | 254604101 | 16,994,205 | 294,221 | SH | SOLE | 294,221 | 0 | 0 | |||
ENLIVEN THERAPEUTICS INC | COM | 29337E102 | 71,427,894 | 5,160,975 | SH | SOLE | 5,160,975 | 0 | 0 | |||
ENTRADA THERAPEUTICS INC | COM | 29384C108 | 66,522,439 | 4,408,379 | SH | SOLE | 4,408,379 | 0 | 0 | |||
GH RESEARCH PLC | ORDINARY SHARES | G3855L106 | 2,345,543 | 404,404 | SH | SOLE | 404,404 | 0 | 0 | |||
HOMOLOGY MEDICINES INC | COM | 438083107 | 2,757,839 | 4,535,919 | SH | SOLE | 4,535,919 | 0 | 0 | |||
MERSANA THERAPEUTICS INC | COM | 59045L106 | 3,027,600 | 1,305,000 | SH | SOLE | 1,305,000 | 0 | 0 | |||
MERUS N V | COM | N5749R100 | 14,342,103 | 521,531 | SH | SOLE | 521,531 | 0 | 0 | |||
MIRATI THERAPEUTICS INC | COM | 60468T105 | 11,309,375 | 192,500 | SH | SOLE | 192,500 | 0 | 0 | |||
MOONLAKE IMMUNOTHERAPEUTICS | CLASS A ORD | 61559X104 | 18,275,826 | 302,630 | SH | SOLE | 302,630 | 0 | 0 | |||
PHARVARIS N V | COM | N69605108 | 22,372,680 | 797,600 | SH | SOLE | 797,600 | 0 | 0 | |||
RALLYBIO CORP | COM | 75120L100 | 8,677,430 | 3,630,724 | SH | SOLE | 3,630,724 | 0 | 0 | |||
SCPHARMACEUTICALS INC | COM | 810648105 | 7,528,057 | 1,200,647 | SH | SOLE | 1,200,647 | 0 | 0 | |||
SPRUCE BIOSCIENCES INC | COM | 85209E109 | 6,926,520 | 2,364,000 | SH | SOLE | 2,364,000 | 0 | 0 | |||
TYRA BIOSCIENCES INC | COM | 90240B106 | 7,686,459 | 554,979 | SH | SOLE | 554,979 | 0 | 0 | |||
VIKING THERAPEUTICS INC | COM | 92686J106 | 10,886,850 | 585,000 | SH | SOLE | 585,000 | 0 | 0 | |||
VIRIDIAN THERAPEUTICS INC | COM | 92790C104 | 12,776,039 | 586,595 | SH | SOLE | 586,595 | 0 | 0 | |||
VOR BIOPHARMA INC | COM | 929033108 | 14,313,877 | 6,361,723 | SH | SOLE | 6,361,723 | 0 | 0 | |||
ZENTALIS PHARMACEUTICALS INC | COM | 98943L107 | 7,423,500 | 490,000 | SH | SOLE | 490,000 | 0 | 0 |